Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing In Vivo Epitopes of Its γ Chain One of Which Is Not Cross Reactive With Anti-Citrullinated Protein Antibodies
To identify the targets recognized by anti-carbamylated protein antibodies (anti-CarP) in patients with early Rheumatoid Arthritis (RA), to study the cross-reactivity between anti-CarP and anti-citrullinated protein antibodies (ACPA) and to evaluate their prognostic value. 331 patients (184 RA and 1...
Main Authors: | Pauline Brevet, Claire Lattard, Clément Guillou, Pascal Rottenberg, Patrice Fardellone, Xavier Le-Loët, Thierry Lequerré, Pascal Cosette, Olivier Boyer, Manuel Fréret, Olivier Vittecoq |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.733511/full |
Similar Items
-
Anti-Carbamylated Protein (Anti-CarP) Antibodies in Patients Evaluated for Suspected Rheumatoid Arthritis
by: Vincent Ricchiuti, et al.
Published: (2022-07-01) -
Anti-carbamylated protein antibodies in systemic sclerosis
by: Sophie I. E. Liem, et al.
Published: (2023-07-01) -
From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
by: Chao-Yi Wu, et al.
Published: (2021-01-01) -
Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis
by: Shuichiro Nakabo
Published: (2019-01-01) -
Identification of S100A9 as biomarker of responsiveness to the methotrexate/etanercept combination in rheumatoid arthritis using a proteomic approach.
by: Antoine Obry, et al.
Published: (2014-01-01)